Targeting co-stimulatory molecules in autoimmune disease
- 16 September 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 19 (12), 860-883
- https://doi.org/10.1038/s41573-020-0081-9
Abstract
Therapeutic targeting of immune checkpoints has garnered significant attention in the area of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T lymphocyte antigen 4 (CTLA4) and PD1, both of which are members of the CD28 family. In autoimmunity, these same pathways can be targeted to opposite effect: to curb the over-exuberant immune response. The CTLA4 checkpoint serves as an exemplar, whereby CTLA4 activity is blocked by antibodies in cancer immunotherapy and augmented by the provision of soluble CTLA4 in autoimmunity. Here, we review the targeting of co-stimulatory molecules in autoimmune diseases, focusing in particular on agents directed at members of the CD28 or tumour necrosis factor receptor families. We present the state of the art in co-stimulatory blockade approaches, including rational combinations of immune inhibitory agents, and discuss the future opportunities and challenges in this field.Keywords
This publication has 235 references indexed in Scilit:
- Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor TriggeringJournal of Biological Chemistry, 2011
- Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Epithelial cells as immune effector cells: The role of CD40Seminars in Immunology, 2009
- The role of CD40 and CD154/CD40L in dendritic cellsSeminars in Immunology, 2009
- B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humansProceedings of the National Academy of Sciences of the United States of America, 2009
- The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cellsNature Immunology, 2008
- The Immunological Genome Project: networks of gene expression in immune cellsNature Immunology, 2008
- Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survivalProceedings of the National Academy of Sciences of the United States of America, 2006
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002